Programmed Cell Death Protein 4 (PDCD4) Peptide

Por favor contáctenos para obtener información detallada sobre el precio y disponibilidad.
Description
Programmed Cell Death Protein 4 (PDCD4) Peptide is a synthetic peptide.
Documents del producto
Product specifications
| Category | Proteins and Peptides  | 
| Immunogen Target | Programmed Cell Death Protein 4 (PDCD4)  | 
| Host | Synthetic  | 
| Recommended Dilution | BL (predicted): 0.5 mg/ml. Optimal dilutions/concentrations should be determined by the end user.  | 
| Conjugation | Unconjugated  | 
| Observed MW | Sequence Fragment: Internal region: DSYKGTVDCVQAR  | 
| Size 1 | 100 µg  | 
| Form | Lyophilized Reconstitute in deionized water.  | 
| Tested Applications | P-ELISA  | 
| Buffer | Prior to lyophilization: Deionized water.  | 
| Availability | Shipped within 5-10 working days.  | 
| Storage | Aliquot and store at -20°C. Avoid repeated freeze/thaw cycles.  | 
| Dry Ice | No  | 
| Gene ID | 27250, 18569, 64031  | 
| NCBI Accession | NP_055271.2, NP_663314.1, NP_001186421.1  | 
| Background | Protein PDCD4  | 
| Note | This product is for research use only. Not for human consumption, cosmetic, therapeutic or diagnostic use.  | 
Descripción
Related Products

Human PDCD4 (Programmed cell death protein 4) ELISA Kit
Ver Producto
PDCD4 antibody
Inhibits translation initiation and cap-dependent translation. May excert its function by hindering the interaction between EIF4A1 and EIF4G. Inhibits the helicase activity of EIF4A. Modulates the activation of JUN kinase. Down-regulates the expression of MAP4K1, thus inhibiting events important in driving invasion, namely, MAPK85 activation and consequent JUN-dependent transcription. May play a role in apoptosis. Tumor suppressor. Inhibits tumor promoter-induced neoplastic transformation. Binds RNA(By similarity).
Ver Producto
PDCD4 antibody
Inhibits translation initiation and cap-dependent translation. May excert its function by hindering the interaction between EIF4A1 and EIF4G. Inhibits the helicase activity of EIF4A. Modulates the activation of JUN kinase. Down-regulates the expression of MAP4K1, thus inhibiting events important in driving invasion, namely, MAPK85 activation and consequent JUN-dependent transcription. May play a role in apoptosis. Tumor suppressor. Inhibits tumor promoter-induced neoplastic transformation. Binds RNA(By similarity).
Ver Producto